US Firm’s £500m Campus Investment Hailed as ‘Show of Confidence’

Chancellor Rachel Reeves characterized a £500m private investment from an American company into a British research campus as a “real show of confidence in what this government are doing”. This investment, made by the San Francisco-headquartered developer Prologis and disclosed shortly after Ms. Reeves’s budget announcement, is designated to finance an expansion of 115,000 sq ft (10,684 sq m) at its Cambridge Biomedical Campus. Currently, the campus supports over 22,000 jobs and contributes £4.2bn annually to the United Kingdom’s economy. Ms. Reeves stated that this expansion is expected to “support the growth of the life science industry in Britain”. She further commented: “The UK’s got huge strengths in industries like this, but this additional investment means we create more good jobs, paying decent wages as well as developing lifesaving drugs.” She added: “That’s incredibly exciting because that means patients in the UK having access to better quality medicines while also building our research capability.” The forthcoming development is planned to accommodate high-tech laboratories, facilitating clinical trials and diagnostic services. Paul Weston, the regional head for Prologis UK, described the initiative as “a continuation of the investment we have put in this location for over 20 years now”. He also stated: “There is a lot riding on this pivotal first budget and strong support from the private sector to follow through on investment pledges will be critical.” Weston further remarked: “We look forward to furthering our collaboration and investment activity, ensuring the UK continues to lead on a global stage.” Mr. Weston additionally noted that this latest phase of the campus is projected to generate approximately 2,700 jobs and constitutes “critical infrastructure for the UK”.